RN

Rakesh Niranjan Mehta

Active Director Director DIN 06430865
DIN 06430865 First appointment Dec 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2012
Shareholding value •••• Premium profile

About Rakesh Niranjan Mehta

Data last updated:

Rakesh Niranjan Mehta is a Director at Glester Pharmaceuticals Private Limited (since 2012). The company operates in Pharma. Glester Pharmaceuticals Private Limited reported revenue of ₹45 Lakh (FY 2024).

DIN 06430865
Primary Designation Director
Industry Pharma
First Appointment 19 Dec 2012
Oldest Company Age 13 yrs
Largest company Glester Pharmaceuticals Private Limited · ₹45 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 20122012₹45 Lakh (FY 2024)Active

Board colleagues of Rakesh Niranjan Mehta

NameDINCompanyDesignation
Punita Rakesh Mehta06685140Glester Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glester Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Niranjan Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Niranjan Mehta

Rakesh Niranjan Mehta currently holds 1 directorship: Glester Pharmaceuticals Private Limited (Director, since 19 Dec 2012, revenue ₹45 Lakh (FY 2024)).

Rakesh Niranjan Mehta was first appointed on 19 Dec 2012 as Director at Glester Pharmaceuticals Private Limited.

The current boards of Rakesh Niranjan Mehta's companies include Punita Rakesh Mehta (Glester Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available